The Megyn Kelly Show A Deep Dive Into Alzheimer's and Disturbing New Scientific Findings, with Dr. Dale Bredesen, Dr. Matthew Schrag, and Charles Piller | Ep. 373
Aug 15, 2022
Join Dr. Matthew Schrag, a neuroscientist known for exposing fraud in Alzheimer's research, alongside investigative journalist Charles Piller, as they delve into the ethics of scientific integrity. Dr. Dale Bredesen, renowned for his work on Alzheimer's, discusses alternative treatment approaches amid controversy over drug efficacy and manipulated data. They tackle the amyloid hypothesis, the significance of lifestyle factors like diet, and the need for transparency in research. Plus, discover insights on genetic risk factors and proactive measures to enhance brain health.
AI Snips
Chapters
Books
Transcript
Episode notes
Aduhelm Criticism
- Dr. Schrag was initially critical of the Alzheimer's drug Aduhelm (Aducanumab).
- He questioned its efficacy and high cost, leading to national media attention.
Simufilam Investigation
- Dr. Schrag investigated Cassava Science's drug, Simufilam, for potential data manipulation.
- He discovered concerning image artifacts, raising questions about research misconduct.
Influential 2006 Study
- Dr. Lesné and Dr. Ashe's 2006 Alzheimer's study significantly influenced research direction.
- This study, now under scrutiny, suggested a link between amyloid plaques and Alzheimer's.
